- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenetics of Antipsychotics
Authors
Keywords
-
Journal
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
Volume 59, Issue 2, Pages 76-88
Publisher
SAGE Publications
Online
2017-07-20
DOI
10.1177/070674371405900203
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- From Pharmacogenetics to Pharmacogenomics: The Way toward the Personalization of Antidepressant Treatment
- (2017) Chiara Fabbri et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation
- (2014) N Fleeman et al. HEALTH TECHNOLOGY ASSESSMENT
- Association Between Common Variants Near the Melanocortin 4 Receptor Gene and Severe Antipsychotic Drug–Induced Weight Gain
- (2012) Anil K. Malhotra ARCHIVES OF GENERAL PSYCHIATRY
- Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene
- (2012) N I Chowdhury et al. PHARMACOGENOMICS JOURNAL
- Using a pharmacogenomic algorithm to guide the treatment of depression
- (2012) D K Hall-Flavin et al. Translational Psychiatry
- Haematological toxicity of clozapine and some other drugs used in psychiatry
- (2011) Patty M. M. Nooijen et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Association study of MC4R with complex obesity and replication of the rs17782313 association signal
- (2011) Sigri Beckers et al. MOLECULAR GENETICS AND METABOLISM
- Genetic variation in CYP3A43 explains racial difference in olanzapine clearance
- (2011) K L Bigos et al. MOLECULAR PSYCHIATRY
- Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications
- (2011) T A P Lett et al. MOLECULAR PSYCHIATRY
- Functional consequences of twoHTR2Cpolymorphisms associated with antipsychotic-induced weight gain
- (2011) Matthew J Hill et al. PHARMACOGENOMICS
- Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications
- (2011) Amy K Lee et al. PHARMACOGENOMICS
- Genetics of Antipsychotic-induced Side Effects and Agranulocytosis
- (2011) Nabilah I. Chowdhury et al. Current Psychiatry Reports
- D2Receptor Genetic Variation and Clinical Response to Antipsychotic Drug Treatment: A Meta-Analysis
- (2010) Jian-Ping Zhang et al. AMERICAN JOURNAL OF PSYCHIATRY
- The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone
- (2010) Nikolina Jovanović et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic variants in the BDNF gene and therapeutic response to risperidone in schizophrenia patients: a pharmacogenetic study
- (2010) Mingqing Xu et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians
- (2010) Renan P. Souza et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction
- (2010) Jian-Ping Zhang et al. Expert Opinion on Drug Metabolism & Toxicology
- Association study of polymorphisms in Insulin Induced Gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients
- (2010) Arun K. Tiwari et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response
- (2010) Renan P. Souza et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Cytochrome P450 and ABCB1 genetics: association with quetiapine and norquetiapine plasma and cerebrospinal fluid concentrations and with clinical response in patients suffering from schizophrenia. A pilot study
- (2010) Georg Nikisch et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs
- (2010) D E Adkins et al. MOLECULAR PSYCHIATRY
- Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia
- (2010) Lior Greenbaum et al. MOVEMENT DISORDERS
- Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia
- (2010) Joseph L McClay et al. NEUROPSYCHOPHARMACOLOGY
- Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment
- (2010) Chen-Jee Hong et al. Pharmacogenetics and Genomics
- Association ofHTR2C, but notLEPorINSIG2, genes with antipsychotic-induced weight gain in a German sample
- (2010) Carolin Opgen-Rhein et al. PHARMACOGENOMICS
- Polymorphisms of theHTR2Cgene and antipsychotic-induced weight gain: an update and meta-analysis
- (2010) Michelle N Sicard et al. PHARMACOGENOMICS
- Genome-wide association study of antipsychotic-induced QTc interval prolongation
- (2010) K Åberg et al. PHARMACOGENOMICS JOURNAL
- Systematic analysis of dopamine receptor genes (DRD1–DRD5) in antipsychotic-induced weight gain
- (2010) D J Müller et al. PHARMACOGENOMICS JOURNAL
- Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia
- (2010) M R Kuzman et al. PHARMACOGENOMICS JOURNAL
- Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients
- (2010) Arun K. Tiwari et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- MDR1 gene polymorphisms and response to acute risperidone treatment
- (2010) Matej Kastelic et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Serotonin transporter polymorphisms and early response to antipsychotic treatment in first episode of psychosis
- (2010) Javier Vázquez-Bourgon et al. PSYCHIATRY RESEARCH
- Catechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosis
- (2010) José María Pelayo-Terán et al. PSYCHIATRY RESEARCH
- Variants in the oxytocin gene and risk for schizophrenia
- (2010) Renan P. Souza et al. SCHIZOPHRENIA RESEARCH
- The catechol-O-methyl-transferase gene in tardive dyskinesia
- (2010) Clement C. Zai et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Identification of Novel Candidate Genes for Treatment Response to Risperidone and Susceptibility for Schizophrenia: Integrated Analysis Among Pharmacogenomics, Mouse Expression, and Genetic Case-Control Association Approaches
- (2009) Masashi Ikeda et al. BIOLOGICAL PSYCHIATRY
- Body weight gain induced by atypical antipsychotics: an extension of the monocygotic twin and sib pair study
- (2009) S. Gebhardt et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Multiple Genetic Factors in Olanzapine-Induced Weight Gain in Schizophrenia Patients
- (2009) Hiroshi Ujike et al. JOURNAL OF CLINICAL PSYCHIATRY
- Impact of CYP2D6 Genotype on Steady-State Serum Concentrations of Risperidone and 9-Hydroxyrisperidone in Patients Using Long-Acting Injectable Risperidone
- (2009) Magnhild Hendset et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients
- (2009) J. Du et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics
- (2009) J L McClay et al. MOLECULAR PSYCHIATRY
- CYP2D6 Genotype Predicts Antipsychotic Side Effects in Schizophrenia Inpatients: A Retrospective Matched Case-Control Study
- (2009) Camilla J. Kobylecki et al. NEUROPSYCHOBIOLOGY
- Association analysis between functional polymorphism of the rs4606 SNP in the RGS2 gene and antipsychotic-induced Parkinsonism in Japanese patients with schizophrenia: Results from the Juntendo University Schizophrenia Projects (JUSP)
- (2009) Masayuki Higa et al. NEUROSCIENCE LETTERS
- Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophrenia
- (2009) Anna Schuhmacher et al. Pharmacogenetics and Genomics
- CYP2D6genotyping for psychiatric patients treated with risperidone: considerations for cost–effectiveness studies
- (2009) Cristina Rodríguez-Antona et al. PHARMACOGENOMICS
- Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients
- (2009) C C Zai et al. PHARMACOGENOMICS JOURNAL
- Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening?
- (2009) B Laika et al. PHARMACOGENOMICS JOURNAL
- Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome
- (2009) B Laika et al. PHARMACOGENOMICS JOURNAL
- Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant
- (2009) R Hwang et al. PHARMACOGENOMICS JOURNAL
- Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia
- (2009) A.F.Y. Al Hadithy et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients
- (2009) Ana Alkelai et al. PSYCHOPHARMACOLOGY
- MDR1 gene in tardive dyskinesia scale scores: Comparison of strategies for quantitative trait haplotype analysis
- (2009) Vincenzo De Luca et al. SCHIZOPHRENIA RESEARCH
- Excess of transmission of the G allele of the -1438A/G polymorphism of the 5-HT2Areceptor gene in patients with schizophrenia responsive to antipsychotics
- (2008) Dalila Benmessaoud et al. BMC Psychiatry
- CYP2D6*3, *4, *5 AND *6 POLYMORPHISMS AND ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SIDE-EFFECTS IN PATIENTS RECEIVING ANTIPSYCHOTIC THERAPY
- (2008) Anna Crescenti et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- SNAP-25 gene polymorphisms and weight gain in schizophrenic patients
- (2008) Richard Musil et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment
- (2008) B Wilffert et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions
- (2008) P R Bakker et al. MOLECULAR PSYCHIATRY
- Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
- (2008) S Le Hellard et al. MOLECULAR PSYCHIATRY
- Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
- (2008) M Kato et al. MOLECULAR PSYCHIATRY
- Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study
- (2008) C Lavedan et al. MOLECULAR PSYCHIATRY
- Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia
- (2008) Rainald Mössner et al. Pharmacogenetics and Genomics
- Clozapine-induced agranulocytosis and its genetic determinants
- (2008) Carolin Opgen-Rhein et al. PHARMACOGENOMICS
- G-protein gene 825C>T polymorphism is associated with response to clozapine in Brazilian schizophrenics
- (2008) Fabiana B Kohlrausch et al. PHARMACOGENOMICS
- Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia
- (2008) Masashi Ikeda et al. PHARMACOGENOMICS
- Association of antipsychotic induced weight gain and body mass index with GNB3 gene: A meta-analysis
- (2008) Renan P. Souza et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Acute antipyschotic efficacy and side effects in schizophrenia: Association with serotonin transporter promoter genotypes
- (2008) Vita Dolžan et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The influence of 5-HT2C and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients
- (2008) Martina Rojnic Kuzman et al. PSYCHIATRY RESEARCH
- Correlates of response to Olanzapine in a North Indian Schizophrenia sample
- (2008) Pramod Thomas et al. PSYCHIATRY RESEARCH
- Pharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use?
- (2008) M. J. Arranz et al. SCHIZOPHRENIA BULLETIN
- Schizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiology
- (2008) R TANDON et al. SCHIZOPHRENIA RESEARCH
- Associations between MDR1 gene polymorphisms and schizophrenia and therapeutic response to olanzapine in female schizophrenic patients
- (2006) Nada Bozina et al. JOURNAL OF PSYCHIATRIC RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More